COVID-19 Vaccine Doses: Who’s Got At Least One?
With COVID-19 vaccine rollouts well underway in some countries, a return to ‘normal life’ could come sooner than later.
That said, many jurisdictions have experienced serious delays and supply shortages that have made it difficult to distribute COVID-19 vaccine doses to their populations. As of mid-February, 130 countries had not been able to begin vaccinating at all.
This interactive chart from Our World in Data tracks the share of people in each country that have received COVID-19 vaccine doses so far.
The Global Vaccine Rollout
As of publication date, roughly 100 countries have begun vaccine distribution, with about seven different vaccines available for public use at this stage.
The sheer logistical challenge of doling out vaccines is immense. Experts estimate that 70-80% of the world’s population will need to be vaccinated to reach herd immunity. Additionally, some of the vaccines require two doses which adds extra time and complexity to the process.
Here’s how the various vaccines compare in terms of required doses and levels of effectiveness.
|Vaccine||Number of Shots Required||Effectiveness|
|Johnson & Johnson||1||66%|
|Novavax (*Novavax has not yet been approved for public use)||2||89%|
Source: Bloomberg Vaccine Tracker
One key barrier to successfully administering vaccines is the prevalence of vaccine hesitancy around the globe.
For example, many people in Germany have been refusing the AstraZeneca vaccine due to a belief in its ineffectiveness and a preference for the ‘in-house’ German Pfizer/BioNTech vaccine. Although 1.45 million AstraZeneca COVID-19 vaccine doses have arrived in the country so far, just 270,000 have been administered.
Who’s Got at Least One Dose?
According to Bloomberg’s Vaccine Tracker, the current rate of doses being administered globally is more than 6 million per day. In particular, the U.S. has been remarkably efficient at administering doses, with a vaccine administration rate of over 1.7 million per day.
Here’s a breakdown of the countries who have begun vaccinating their populations and their current daily rate of doses administered.
|Country||Daily Rate of Doses Administered|
|🇰🇾 Cayman Islands||621|
|🇨🇷 Costa Rica||706|
|🇨🇿 Czech Republic||15,298|
|🇩🇴 Dominican Republic||9,356|
|🇮🇲 Isle of Man||599|
|🇸🇦 Saudi Arabia||34,180|
|🇿🇦 South Africa||7,569|
|🇱🇰 Sri Lanka||4,755|
Source: Bloomberg Vaccine Tracker. Data as of Feb 28, 2021.
Certain countries appear to be on track to distribute all of their COVID-19 vaccine doses at an immensely quick rate. For example, the UK plans to vaccinate enough people to be able to lift all lockdown restrictions completely by the end of June 2021.
Additionally, the first COVAX rollouts have officially begun; COVAX is an initiative working to ensure equitable access to COVID-19 vaccines. Ghana was the first country to receive doses through the initiative.
Back to Normal?
Most countries are prioritizing vaccinating their high-risk groups first, from older adults to healthcare workers. That said, the planning required to vaccinate an entire population needs to be carefully thought out and often comes with immense logistical challenges.
While many countries have begun to immunize their populations, others have not been able to purchase doses yet. At the current pace, it could take a few years before things are completely back to normal and we reach herd immunity globally.
Visualizing the World’s Biggest Pharmaceutical Companies
The world’s biggest pharmaceutical companies are worth $4.1 trillion. Here we map the top 100 companies based on their market cap value.
Who are the World’s Biggest Pharmaceutical Companies?
Some of the world’s biggest pharmaceutical companies have played a central role in the COVID-19 pandemic.
However, it’s likely no surprise that the pandemic has also been great for many healthcare businesses. In fact, in 2020 alone, the world’s 50 largest pharmaceutical companies still combined for a whopping $851 billion in revenues.
In this graphic, using data from Companies Market Cap, we list the largest pharmaceutical companies in the world by market capitalization. It’s worth noting this list also includes healthcare companies that work closely with pharmaceuticals, including biotech, pharmaceutical retailers, clinical laboratories, etc.
Editor’s Note: A previous version of this graphic was missing some key companies such as GSK and AbbVie. They were unfortunately not included in the original source and we are now working to make sure there were no other smaller omissions. Thanks to all that sent in corrections.
The Pharmaceutical Leaders
To start, here are the top five biggest pharmaceutical companies in the world at the moment by market capitalization:
1. Johnson & Johnson
The pharmaceutical and consumer goods giant is worth $428.7 billion in market cap. They developed the third vaccine authorized for use in the U.S. and were named among the TIME100 Most Influential Companies List in 2021.
The Swiss pharmaceutical giant is at the forefront of oncology, immunology, infectious diseases, ophthalmology, and neuroscience. In 2019, Roche’s pharma segment sales rose by a healthy 16% to $53 billion.
Despite being the leading COVID-19 vaccine manufacturer in North America, Pfizer slid in the rankings to third place. The company has recently gained momentum, especially in the past quarter, with Q2’2021 revenues of $19.0 billion, reflecting a 86% operational growth from 2020.
4. Eli Lilly
Eli Lilly has taken a significant step towards establishing itself as a pharmaceutical industry leader. Having a market cap value of $125 billion in 2019, Eli Lilly has jumped to a current value of $214.9 billion, a significant growth of 72%.
The second-biggest pharmaceutical company out of Switzerland, Novartis has been the face of the pharma industry for about 25 years. The primary manufacturer for the most recognizable drugs on the market pulled in a revenue of over $48 billion in 2020, a 3% increase compared to 2019.
Here’s how all the biggest pharmaceutical companies in the world stack up against each other:
|Company Rank||Company Name||Market Cap Value||Country|
|1||Johnson & Johnson|
|$428.66 B||🇺🇸 USA|
|$320.41 B||🇨🇭 Switzerland|
|$219.39 B||🇺🇸 USA|
|$208.99 B||🇺🇸 USA|
|$207.70 B||🇨🇭 Switzerland|
|$202.60 B||🇺🇸 USA|
|$191.67 B||🇺🇸 USA|
|$187.83 B||🇩🇰 Denmark|
|$152.28 B||🇬🇧 UK|
|$145.80 B||🇺🇸 USA|
|$136.50 B||🇺🇸 USA|
|$130.37 B||🇫🇷 France|
|$110.49 B||🇺🇸 USA|
|$104.30 B||🇬🇧 UK|
|$103.10 B||🇦🇺 Australia|
|$83.62 B||🇺🇸 USA|
|$83.25 B||🇺🇸 USA|
|$80.61 B||🇩🇪 Germany|
|$59.43 B||🇩🇪 Germany|
|20||Jiangsu Hengrui Medicine |
|$58.51 B||🇨🇳 China|
|$55.83 B||🇺🇸 USA|
|$55.00 B||🇺🇸 USA|
|$54.23 B||🇩🇪 Germany|
|$52.67 B||🇯🇵 Japan|
|$52.16 B||🇨🇭 Switzerland|
|26||Walgreens Boots Alliance|
|$45.05 B||🇺🇸 USA|
|$33.80 B||🇰🇷 S. Korea|
|$33.42 B||🇯🇵 Japan|
|$31.65 B||🇨🇳 China|
|$31.20 B||🇯🇵 Japan|
|$26.59 B||🇺🇸 USA|
|32||Hansoh Pharma |
|$26.00 B||🇨🇳 China|
|$25.97 B||🇺🇸 USA|
|34||Otsuka Holdings |
|$23.15 B||🇯🇵 Japan|
|35||Horizon Therapeutics |
|$21.13 B||🇮🇪 Ireland|
|36||Alnylam Pharmaceuticals |
|$20.42 B||🇺🇸 USA|
|$18.85 B||🇯🇵 Japan|
|$18.74 B||🇺🇸 USA|
|$18.48 B||🇭🇰 Hong Kong|
|$17.25 B||🇺🇸 USA|
|$16.26 B||🇺🇸 USA|
|$16.03 B||🇳🇱 Netherlands|
|$15.29 B||🇯🇵 Japan|
|$11.88 B||🇮🇳 India|
|45||Teva Pharmaceutical Industries|
|$11.21 B||🇮🇱 Israel|
|46||Ono Pharmaceutical |
|$11.12 B||🇯🇵 Japan|
|$11.09 B||🇮🇪 Ireland|
|48||Bausch Health |
|$10.47 B||🇨🇦 Canada|
|$10.42 B||🇨🇭 Switzerland|
|$10.33 B||🇩🇪 Germany|
|51||Hualan Biological Engineering|
|$10.31 B||🇨🇳 China|
|$9.49 B||🇨🇭 Switzerland|
|53||Neurocrine Biosciences |
|$9.45 B||🇺🇸 USA|
|$9.42 B||🇨🇳 China|
|55||BridgeBio Pharma |
|$8.89 B||🇺🇸 USA|
|56||Cadila Healthcare |
|$8.59 B||🇮🇳 India|
|57||Sumitomo Dainippon Pharma |
|$8.16 B||🇯🇵 Japan|
|$7.89 B||🇨🇦 Canada|
|59||Ascendis Pharma |
|$7.51 B||🇩🇰 Denmark|
|$7.19 B||🇩🇪 Germany|
|61||Lupin Limited |
|$7.04 B||🇮🇳 India|
|62||Gland Pharma |
|$7.01 B||🇮🇳 India|
|$6.95 B||🇺🇸 USA|
|64||GW Pharmaceuticals |
|$6.81 B||🇬🇧 UK|
|$6.78 B||🇯🇵 Japan|
|66||Torrent Pharmaceuticals |
|$6.61 B||🇮🇳 India|
|$6.43 B||🇮🇳 India|
|$6.32 B||🇯🇵 Japan|
|69||Sarepta Therapeutics |
|$6.25 B||🇺🇸 USA|
|$6.21 B||🇮🇪 Ireland|
|$6.11 B||🇫🇮 Finland|
|$6.04 B||🇩🇰 Denmark|
|$5.87 B||🇨🇦 Canada|
|74||Adaptive Biotechnologies |
|$5.69 B||🇺🇸 USA|
|75||Intellia Therapeutics |
|$5.62 B||🇺🇸 USA|
|76||Santen Pharmaceutical |
|$5.49 B||🇯🇵 Japan|
|$5.46 B||🇯🇵 Japan|
|78||Beam Therapeutics |
|$5.43 B||🇺🇸 USA|
|79||Reata Pharmaceuticals |
|$5.15 B||🇺🇸 USA|
|80||Swedish Orphan Biovitrum|
|$5.13 B||🇸🇪 Sweden|
|81||BB Biotech |
|$5.08 B||🇨🇭 Switzerland|
|82||Alkem Laboratories |
|$5.00 B||🇮🇳 India|
|$4.69 B||🇮🇳 India|
|84||Laurus Labs |
|$4.44 B||🇮🇳 India|
|85||Taisho Pharmaceutical |
|$4.39 B||🇯🇵 Japan|
|86||Hanmi Pharmaceutical |
|$4.22 B||🇰🇷 S. Korea|
|$3.87 B||🇮🇪 Ireland|
|$3.71 B||🇺🇸 USA|
|$3.65 B||🇰🇷 S. Korea|
|$3.55 B||🇺🇸 USA|
|91||Ipca Laboratories |
|$3.41 B||🇮🇳 India|
|92||Nektar Therapeutics |
|$3.02 B||🇺🇸 USA|
|93||BioCryst Pharmaceuticals |
|$3.01 B||🇺🇸 USA|
|$2.96 B||🇺🇸 USA|
|$2.84 B||🇺🇸 USA|
|96||Rocket Pharmaceuticals |
|$2.74 B||🇺🇸 USA|
|97||Axsome Therapeutics |
|$2.65 B||🇺🇸 USA|
|98||Natco Pharma |
|$2.63 B||🇮🇳 India|
|$2.59 B||🇮🇳 India|
|100||Editas Medicine |
|$2.54 B||🇺🇸 USA|
World’s Largest Pharmaceutical Exporters and Importers
According to the World Trade Organization (WTO), these countries exported the most number of pharmaceuticals in the year 2019:
|Rank||Country||Export Value (US$B)|
In contrast, here are the biggest importers over the same period.
|Rank||Country||Import Value (US$B)|
This position is hardly surprising for the U.S., where six of the world’s top 10 pharmaceutical companies are headquartered. The country also captures 45% of the global market.
The Future of Pharmaceutical Companies
If the response to the COVID-19 pandemic has taught us anything, it is that in building a patient-centered future, the pharmaceutical industry plays a key role. It has to constantly find new ways to customize medicines while researching and developing new tools and drugs.
By embracing disruptive technologies like 3D printed drugs, artificial intelligence guided therapies, and preventive medicine while working with regulatory agencies, the pharmaceutical companies will benefit from having a digital revolution.
Furthermore, emerging markets will have a more significant say in the global pharmaceutical market in the coming years. Even though ‘big pharma’ will keep raking in the massive profits they do every year, their reliance on countries like Brazil and India for research and drug production will significantly impact the years to come.
When Will Your Country Recover from the Pandemic?
The path to COVID-19 recovery varies worldwide—some countries have already recovered, while others will not be back to normal for years.
What started as a novel virus in China quickly became a sweeping disease that shut down the world and put a 1.5 year halt on the global economy.
But while some countries’ economies are already back to normal, others are lagging far behind.
COVID-19 Recovery Timelines, by OECD Country
This chart using data from the OECD anticipates when countries will economically recover from the global pandemic, based on getting back to pre-pandemic levels of GDP per capita.
Note: The categorization of ‘advanced’ or ‘emerging’ economy was determined by OECD standards.
The Leaders of the Pack
At the top, China and the U.S. are recovering at breakneck speed. In fact, recovering is the wrong word for China, as they reached pre-pandemic GDP per capita levels just after Q2’2020.
On the other end, some countries are looking at years—not months—when it comes to their recovery date. Saudi Arabia isn’t expected to recover until after Q1’2024, and Argentina is estimated to have an even slower recovery, occurring only after Q2’2026.
|🇧🇪 Belgium||After Q4 2022||Advanced|
|🇸🇪 Sweden||After Q4 2021||Advanced|
|🇸🇰 Slovakia||After Q4 2021||Advanced|
|🇳🇿 New Zealand||After Q4 2021||Advanced|
|🇩🇪 Germany||After Q4 2021||Advanced|
|🇪🇪 Estonia||After Q4 2021||Advanced|
|🇩🇰 Denmark||After Q4 2021||Advanced|
|🇮🇸 Iceland||After Q3 2023||Advanced|
|🇸🇮 Slovenia||After Q3 2022||Advanced|
|🇵🇹 Portugal||After Q3 2022||Advanced|
|🇫🇷 France||After Q3 2022||Advanced|
|🇦🇹 Austria||After Q3 2022||Advanced|
|🇵🇱 Poland||After Q3 2021||Advanced|
|🇳🇴 Norway||After Q3 2021||Advanced|
|🇱🇺 Luxembourg||After Q3 2021||Advanced|
|🇱🇻 Latvia||After Q3 2021||Advanced|
|🇯🇵 Japan||After Q3 2021||Advanced|
|🇫🇮 Finland||After Q3 2021||Advanced|
|🇪🇸 Spain||After Q2 2023||Advanced|
|🇬🇧 United Kingdom||After Q2 2022||Advanced|
|🇳🇱 Netherlands||After Q2 2022||Advanced|
|🇮🇹 Italy||After Q2 2022||Advanced|
|🇬🇷 Greece||After Q2 2022||Advanced|
|🇨🇿 Czech Republic||After Q2 2022||Advanced|
|🇨🇦 Canada||After Q2 2022||Advanced|
|🇺🇸 United States||After Q2 2021||Advanced|
|🇰🇷 South Korea||After Q2 2021||Advanced|
|🇮🇪 Ireland||After Q2 2021||Advanced|
|🇨🇭 Switzerland||After Q1 2022||Advanced|
|🇮🇱 Israel||After Q1 2022||Advanced|
|🇭🇺 Hungary||After Q1 2022||Advanced|
|🇦🇺 Australia||After Q1 2022||Advanced|
|🇱🇹 Lithuania||After Q1 2021||Advanced|
|🇿🇦 South Africa||After Q4 2022||Emerging|
|🇮🇩 Indonesia||After Q4 2021||Emerging|
|🇮🇳 India||After Q4 2021||Emerging|
|🇲🇽 Mexico||After Q3 2023||Emerging|
|🇨🇴 Colombia||After Q3 2022||Emerging|
|🇧🇷 Brazil||After Q3 2022||Emerging|
|🇨🇱 Chile||After Q3 2021||Emerging|
|🇹🇷 Turkey||After Q3 2020||Emerging|
|🇦🇷 Argentina||After Q2 2026||Emerging|
|🇨🇷 Costa Rica||After Q2 2023||Emerging|
|🇷🇺 Russia||After Q2 2021||Emerging|
|🇨🇳 China||After Q2 2020||Emerging|
|🇸🇦 Saudi Arabia||After Q1 2024||Emerging|
Most countries will hit pre-pandemic levels of GDP per capita by the end of 2022. The slowest recovering advanced economies—Iceland and Spain—aren’t expected to bounce back until 2023.
Four emerging economies are speeding ahead, and are predicted to get back on their feet by the end of this year or slightly later (if they haven’t already):
- 🇷🇺 Russia: after Q2’2021
- 🇨🇱 Chile: after Q3’2021
- 🇮🇳 India: after Q4’2021
- 🇮🇩 Indonesia: after Q4’2021
However, no recovery is guaranteed, and many countries will continue face setbacks as waves of COVID-19 variants hit—India, for example, was battling its biggest wave as recently as May 2021.
Why are some countries recovering faster than others? One factor seems to be vaccination rates.
|Country||Doses Administered per 100 People||Total Doses Administered||Percent of Population Fully Vaccinated|
|🇬🇧 United Kingdom||122||81,438,892||53%|
|Trinidad and Tobago||27||375,924||11%|
|Saint Vincent and the Grenadines||23||25,509||–|
|West Bank & Gaza||20||958,519||9%|
|São Tomé and Príncipe||18||37,716||5%|
|Bosnia and Herzegovina||14||470,218||5%|
|Republic of the Congo||3||163,742||–|
|Central African Republic||1.7||78,685||–|
|Papua New Guinea||0.6||51,170||<0.1%|
As of July 16th, 2021.
The higher the rate of vaccination, the harder it is for COVID-19 to spread. This gives countries a chance to loosen restrictions, let people get back to work and regular life, and fuel the economy. Additionally, the quicker vaccines are rolled out, the less time there is for variants to mutate.
Another factor is the overall strength of a country’s healthcare infrastructure. More advanced economies often have more ICU capacity, more efficient dissemination of public health information, and, simply, more hospital staff. These traits help better handle the pandemic, with reduced cases, less restrictions, and a speedy recovery.
Finally, the level of government support and fiscal stimulus injected into different economies has determined how swiftly they’ve recovered. Similar to the disparity in vaccine rollouts, there was a significant fiscal stimulus gap, especially during the heat of the pandemic.
Recovering to Normal?
Many experts and government leaders are now advocating for funneling more money into healthcare infrastructure and disease research preventatively. The increased funding now would help stop worldwide shut downs and needless loss of life in future.
Time will tell when we return to “normal” everywhere, however, normal will likely never be the same. Many impacts of the global pandemic will stay with us over the long term.
Green2 weeks ago
The World’s 25 Largest Lakes, Side by Side
Economy2 weeks ago
The 20 Fastest Growing Jobs in the Next Decade
Science4 weeks ago
Comparing the Size of The World’s Rockets, Past and Present
Misc4 weeks ago
Every Single Cognitive Bias in One Infographic
Misc2 weeks ago
All World Languages in One Visualization
Misc3 weeks ago
Razor Thin: A New Perspective on Earth’s Atmosphere
Misc4 weeks ago
Visualizing the Highest-Paid Athletes in 2021
Markets1 week ago
Mapping The Biggest Companies By Market Cap in 60 Countries